Which statement accurately reflects pediatric HIV management?

• A. Dosing is based on weight/age; perinatal exposure management; growth monitoring; family-centered adherence support
• B. Dosing is fixed by age; no growth monitoring
• C. Perinatal exposure irrelevant; no adherence support
• D. Use adult ART regimens for children

Answer: (A)

Pediatric HIV management hinges on dosing that matches the child’s size, attention to perinatal exposure, regular growth monitoring, and strong family-centered adherence support. Dosing must be weight-based (and developmentally appropriate) because pharmacokinetics change as children grow, so amounts are adjusted to keep viral suppression while minimizing toxicity. Perinatal exposure management addresses mother-to-child transmission through maternal treatment during pregnancy and neonatal prophylaxis and early infant testing, guiding ongoing care. Regular growth monitoring is essential since HIV infection and ART can affect growth and development; tracking height, weight, and growth trends helps detect issues early and tailor interventions. Engaging the family and providing adherence support ensures consistent ART administration, which is critical for sustaining viral suppression and preventing resistance.

The other ideas don’t fit pediatric practice: using fixed dosing by age ignores how weight and body composition influence drug levels; omitting growth monitoring misses a key safety and efficacy signal; treating perinatal exposure as irrelevant ignores a central route of infection risk and prevention; and using adult ART regimens in children fails to account for pediatric dosing, formulations, and tolerability.